These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging. de Lucia C; Eguchi A; Koch WJ Front Pharmacol; 2018; 9():904. PubMed ID: 30147654 [TBL] [Abstract][Full Text] [Related]
5. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure. Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019 [TBL] [Abstract][Full Text] [Related]
7. Acute decompensated heart failure: best evidence and current practice. Mehta R; Feldman D Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237 [TBL] [Abstract][Full Text] [Related]
8. Neurohormones and heart failure. Mendzef SD; Slovinski JR Nurs Clin North Am; 2004 Dec; 39(4):845-61. PubMed ID: 15561165 [TBL] [Abstract][Full Text] [Related]
9. The effect of neurohormonal antagonists in reducing heart failure hospitalizations. Williams RE Curr Med Res Opin; 2006 Jan; 22(1):139-50. PubMed ID: 16393440 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine activation as a target of modern chronic heart failure pharmacotherapy. Dobrek Ł; Thor P Acta Pol Pharm; 2011; 68(3):307-16. PubMed ID: 21648184 [TBL] [Abstract][Full Text] [Related]